![](https://www.diabetesnews.com/wp-content/uploads/2014/03/islet-150x150.jpg)
This June, a 41-year-old man became the first European patient with Type 1 to come off insulin therapy after receiving a transplant of pancreatic islet cells using the BioHub technique. This therapy, engineered by the Diabetes Research Institute (DRI), protects transplanted islet cells from immune system attack.